Brief: Actuate Therapeutics To Be Added To Russell 2000 Index
26/11/2024 13:05
Nov 26 (Reuters) - Actuate Therapeutics Inc ACTU.O :
* ACTUATE THERAPEUTICS TO BE ADDED TO RUSSELL 2000® INDEX
Source text: ID:nGNX55whbJ
Further company coverage: ACTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actuate Therapeutics
See all newsActuate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Actuate Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Health Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing